EFFECT: Others
8-K: Current report
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
8-K: Current report
8-K: Current report
DEF 14A: Definitive information statements
4: Statement of changes in beneficial ownership of securities-Director XU CHERYL
4: Statement of changes in beneficial ownership of securities-Director TOOVEY STEPHEN
4: Statement of changes in beneficial ownership of securities-Officer MILLER TYRONE
4: Statement of changes in beneficial ownership of securities-Director FIELD PAUL
4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S
4: Statement of changes in beneficial ownership of securities-Director Allen Charles W
10-Q: Quarterly report
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KNIGHT THERAPEUTICS INC.(9.97%),KNIGHT THERAPEUTICS INTERNATIONAL S.A.(9.97%)
PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Current report
60 DEGREES PHARMACEUTICALS INC C/WTS (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities- Knight Therapeutics Inc
60 DEGREES PHARMACEUTICALS INC C/WTS (TO PUR COM) | 10-K: Annual report
60 DEGREES PHARMACEUTICALS INC C/WTS (TO PUR COM) | 8-K: Current report
No Data